Fresenius Medical Care is set to buy NxStage Medical for about $2 billion. The takeover will bolster Fresenius’ presence in the at-home dialysis market, positioning it to continue profiting if ...

Please provide your email address to receive an email when new articles are posted on . The U.S. Federal Trade Commission voted 3-2 on Feb. 19 to approve the $2 billion merger between Fresenius ...

Discover more of our free reports coverage from other companies within the Medical Appliances & Equipment industry. Pro-TD has currently selected Boston Scientific Corporation (NYSE: BSX) for ...

Fresenius Medical Care, the world's largest provider of dialysis products and services, has signed an agreement to acquire NxStage Medical, Inc., (NxStage) (Nasdaq: NXTM) a U.S.-based medical ...

Fresenius SE & Co.'s minority-owned kidney dialysis business agreed Monday to acquire NxStage Medical Inc. for about $2 billion as part of the German health-care provider's broader push into the U.S.

WASHINGTON (Reuters) - The U.S. Federal Trade Commission has given Germany's Fresenius Medical Care AG and U.S. home dialysis equipment maker NxStage Medical Inc antitrust approval for their merger, ...

Please provide your email address to receive an email when new articles are posted on . Fresenius Medical Care and NxStage Medical have agreed to extend the timeline for closing of Fresenius’s $2 ...

Fresenius Medical Care announced Tuesday it completed the $2 billion acquisition of home dialysis devicemaker NxStage Medical, about a year and a half after the companies first announced the deal. The ...

Simply sign up to the European companies myFT Digest -- delivered directly to your inbox. German healthcare group Fresenius Medical Care has agreed to buy Boston-based medical technology and services ...

Fresenius Medical Care, the world's largest provider of dialysis products and services, has signed an agreement to acquire NxStage Medical, Inc., (NxStage) (NASDAQ: NXTM) a U.S.-based medical ...